Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Viridian Therapeutics Inc’s stock clocked out at $19.67, up 3.36% from its previous closing price of $19.03. In other words, the price has increased by $3.36 from its previous closing price. On the day, 1.09 million shares were traded. VRDN stock price reached its highest trading level at $19.77 during the session, while it also had its lowest trading level at $18.85.
Ratios:
To gain a deeper understanding of VRDN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.55 and its Current Ratio is at 18.55. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Downgraded its rating to Equal Weight and sets its target price to $27 from $37 previously.
Needham reiterated its Buy rating for the stock on September 11, 2024, while the target price for the stock was revised from $30 to $38.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when Beetham Thomas W. bought 5,000 shares for $23.41 per share. The transaction valued at 117,050 led to the insider holds 6,000 shares of the business.
Mahoney Stephen F. bought 21,400 shares of VRDN for $499,262 on Sep 27 ’24. The President and CEO now owns 21,400 shares after completing the transaction at $23.33 per share. On Sep 13 ’24, another insider, Fairmount Funds Management LLC, who serves as the Director of the company, bought 1,600,000 shares for $18.75 each. As a result, the insider paid 30,000,000 and bolstered with 3,445,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1558113920 and an Enterprise Value of 966337600. For the stock, the TTM Price-to-Sale (P/S) ratio is 5276.91 while its Price-to-Book (P/B) ratio in mrq is 3.00. Its current Enterprise Value per Revenue stands at 3199.793 whereas that against EBITDA is -3.421.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $11.40. The 50-Day Moving Average of the stock is -9.23%, while the 200-Day Moving Average is calculated to be 13.65%.
Shares Statistics:
It appears that VRDN traded 1.27M shares on average per day over the past three months and 2595400 shares per day over the past ten days. A total of 79.18M shares are outstanding, with a floating share count of 70.47M. Insiders hold about 11.04% of the company’s shares, while institutions hold 98.98% stake in the company. Shares short for VRDN as of 1732838400 were 8750391 with a Short Ratio of 6.88, compared to 1730332800 on 10020094. Therefore, it implies a Short% of Shares Outstanding of 8750391 and a Short% of Float of 12.550001.
